No Data
No Data
Press Release: Jade Biosciences Completes Closing of Merger With Aerovate Therapeutics and Previously Announced Private Placement of Approximately $300 Million
Aerovate To Carry Out 1-for-35 Reverse Stock Split On April 29th, 2025
Aerovate | 10-Q: Quarterly report
Aerovate To Go Ex-Dividend On April 29th, 2025 With 2.4 USD Dividend Per Share And 1-for-35 Reverse Stock Split
Aerovate Therapeutics Stockholders Approve Proposed Merger With Jade Biosciences; Board Approves 1-for-35 Reverse Stock Split
Express News | Aerovate Therapeutics Inc - Board Approves 1-for-35 Reverse Stock Split